Goldman Sachs Invests in Aragen Life Sciences
Goldman Sachs Invests in Aragen Life Sciences Wednesday, May 19, 2021 11:55AM IST (6:25AM GMT) Hyderabad, India: Aragen Life Sciences (“Aragen”), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced today that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing sharehol...
Aragen Life Sciences Goldman Sachs Goldman Sachs Gvk Biosciences Contract Research Organization Iotech Clients
Source: businesswireindia.com